Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
42.19
+0.27 (0.64%)
Apr 8, 2026, 3:00 PM CST

SHA:600211 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,9782,8003,1282,5452,127
Other Revenue
3.986.736.249.6912.06
2,9822,8073,1342,5552,139
Revenue Growth (YoY)
6.23%-10.45%22.69%19.45%55.75%
Cost of Revenue
171.94162.1158.67204.74225.8
Gross Profit
2,8102,6452,9762,3501,913
Selling, General & Admin
1,7741,6851,8811,5411,254
Research & Development
74.0828.9417.3588.1360.86
Other Operating Expenses
37.7237.138.1732.5426.2
Operating Expenses
1,8851,7511,9371,6621,340
Operating Income
924.66893.441,039688.27572.75
Interest Expense
-12.59-9.48-11.59-14.36-4.33
Interest & Investment Income
8874.3886.2221.352.67
Currency Exchange Gain (Loss)
1.31-2.47-0.11-3.83-4.78
Other Non Operating Income (Expenses)
-0.12-0.17-0.47-0.39-0.35
EBT Excluding Unusual Items
1,001955.691,113691.03565.96
Gain (Loss) on Sale of Investments
-3.72-18.99-210.53-14.17146.47
Gain (Loss) on Sale of Assets
0.081.90.34-0.23-0.17
Asset Writedown
---190.38-218.62-458.06
Other Unusual Items
43213.48186.035.360.64
Pretax Income
1,0411,152898.19463.39254.85
Income Tax Expense
123.6495.0187.9588.0841.82
Earnings From Continuing Operations
916.981,057810.24375.31213.03
Minority Interest in Earnings
20.95-5.79-9.33-5.47-4.09
Net Income
937.931,051800.91369.84208.94
Net Income to Common
937.931,051800.91369.84208.94
Net Income Growth
-10.78%31.26%116.56%77.01%-50.03%
Shares Outstanding (Basic)
322322323323323
Shares Outstanding (Diluted)
322322323323323
Shares Change (YoY)
-0.05%-0.14%0.09%-0.21%0.53%
EPS (Basic)
2.913.262.481.150.65
EPS (Diluted)
2.913.262.481.150.65
EPS Growth
-10.74%31.45%116.37%77.38%-50.29%
Free Cash Flow
988.79957.191,042735.41-59.05
Free Cash Flow Per Share
3.072.973.232.28-0.18
Dividend Per Share
1.7571.9571.4920.5740.260
Dividend Growth
-10.22%31.21%159.93%120.69%-33.72%
Gross Margin
94.23%94.23%94.94%91.98%89.44%
Operating Margin
31.01%31.83%33.14%26.94%26.78%
Profit Margin
31.46%37.46%25.55%14.48%9.77%
Free Cash Flow Margin
33.16%34.10%33.24%28.79%-2.76%
EBITDA
1,002968.641,107757.52654.2
EBITDA Margin
33.61%34.51%35.31%29.65%30.59%
D&A For EBITDA
77.4775.268.0569.2481.45
EBIT
924.66893.441,039688.27572.75
EBIT Margin
31.01%31.83%33.14%26.94%26.78%
Effective Tax Rate
11.88%8.25%9.79%19.01%16.41%
Revenue as Reported
2,9822,807-2,5552,139
Advertising Expenses
10.18.723.50.050.24
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.